News

MedPage Today2h
FDA Approves Novavax COVID-19 Shot, but With Unusual Restrictions
Novavax originally showed its vaccine was safe and effective in a 30,000-person clinical trial. The FDA had been on track to ...
After delay, FDA approves Novavax’s Covid-19 vaccine, but only for older people and those at high risk
After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...
FDA approves Novavax COVID vaccine with new conditions
The U.S. Food and Drug Administration on Friday approved Novavax's COVID-19 vaccine, but placed additional conditions on ...
Econostrum on MSN6h
Novavax Vaccine Gets FDA Approval—But With Strict New Rules
US regulators grant full approval to Novavax shot but sharply limit eligibility. New studies on heart risks required, raising ...
pharmaphorum20h
FDA clears Amgen’s Bkemv as first biosimilar of Soliris
The US FDA has approved the first biosimilar version of AstraZeneca/Alexion’s Soliris therapy for paroxysmal nocturnal haemoglobinuria (PNH) and atypical haemolytic ...
pharmaphorum20h
Novo Nordisk asks FDA not to allow GLP-1 compounding
Novo Nordisk has filed another Citizen's Petition with the FDA seeking to block compounding pharmacies in the US from making versions of one of its GLP-1 agonist drugs. The latest attempt focuses ...